Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proleukin + Rituxan in Intermediate/High-Grade NHL
NCT00045864Phase 2Completed
- Sponsor
- Chiron Corporation
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aldesleukin in non-Hodgkin lymphoma (NHL), sponsored by Chiron Corporation. Primary endpoints: Safety and Effectiveness and Effectiveness. Status: completed.
02
Drugs
aldesleukin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00045864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045864.